Rosebraugh, Matthew <br/><br/>
Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation.  [electronic resource] 

 -  Pharmacology research & perspectives  04 2019 
 - e00473 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2052-1707 
<br/><br/><label>Standard No.: </label>10.1002/prp2.473  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiparkinson Agents--adverse effects<br/>Carbidopa--adverse effects<br/>Cross-Over Studies<br/>Drug Combinations<br/>Drug Liberation<br/>Female<br/>Gels<br/>Humans<br/>Levodopa--adverse effects<br/>Male<br/>Middle Aged<br/>Therapeutic Equivalency